Given that prior proteomics studies also report enrichment of OLFML3 in Aβ plaques relative to surrounding parenchymal tissue in early-onset AD and Down syndrome,38 and in CAA-affected vessels captured by laser microdissection,43 the current work adds further support to this protein as potentially important in CAA and AD. The gene discussed is OLFML3; the disease is Down syndrome.